1. 3016Long-term survival and safety with selexipag in patients with pulmonary arterial hypertension: results from the GRIPHON study and its open-label extension. (28th August 2018) Authors: Galie, N; Gaine, S; Channick, R; Ghofrani, H A; Hoeper, M; Lang, I; McLaughlin, V; Preiss, R; Rubin, L; Shiraga, Y; Simonneau, G; Sitbon, O; Tapson, V; Chin, K Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P2614Factors associated with survival in patients with not-operated chronic thromboembolic pulmonary hypertension (CTEPH) in the modern management era. (28th August 2018) Authors: Taniguchi, Y; Jais, X; Boucly, A; Weatherald, J; Jevnikar, M; Brenot, P; Planche, O; Parent, F; Savale, L; Montani, D; Fadel, E; Humbert, M; Simonneau, G; Sitbon, O Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S109 Targeting the prostacyclin pathway in the treatment of connective tissue disease associated pulmonary arterial hypertension (pah): insights from the randomised controlled griphon trial with selexipag. (15th November 2016) Authors: Coghlan, G; Gaine, S; Channick, R; Scala, L Di; Galiè, N; Ghofrani, HA; Hoeper, MM; Lang, I; McLaughlin, V; Preiss, R; Rubin, LJ; Simonneau, G; Sitbon, O; Tapson, VF; Chin, K Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PS-008 Exposure to vasoconstrictor nasal decongestants in patients with pulmonary arterial hypertension. (24th February 2014) Authors: Perrin, S; Montani, D; Guignabert, C; Savale, L; Sitbon, O; Simmoneau, G; Humbert, M; Chaumais, M Journal: European journal of hospital pharmacy Issue: Volume 21(2014)Supplement 1 Page Start: A146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P17 Pharmacokinetics of macitentan in patients with portopulmonary hypertension: findings from the PORTICO sub-study. (December 2018) Authors: Church, CA; Bosch, J; Cottreel, E; Csonka, D; Hoeper, M; Krowka, M; Martin, N; Kim, NH; Sitbon, O Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. S122 Long-term survival and safety with selexipag in patients with pulmonary arterial hypertension: results from the GRIPHON study and its open-label extension. (December 2018) Authors: Coghlan, JG; Galiè, N; Gaine, S; Channick, R; Ghofrani, H-A; Hoeper, M; Lang, I; McLaughlin, V; Preiss, R; Rubin, L; Shiraga, Y; Simonneau, G; Sitbon, O; Tapson, V; Chin, K Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Issue 1 (14th October 2005) Authors: Nunes, H; Humbert, M; Capron, F; Brauner, M; Sitbon, O; Battesti, J-P; Simonneau, G; Valeyre, D Journal: Thorax Issue: Volume 61:Issue 1(2006) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Auranofin in steroid dependent asthma. Issue 11 (November 1992) Authors: Sitbon, O; Salmeron, S; Duroux, P; Caquet, R Journal: Thorax Issue: Volume 47:Issue 11(1992) Page Start: 992 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Splenectomy and chronic thromboembolic pulmonary hypertension. Issue 12 (5th August 2005) Authors: Jaïs, X; Ioos, V; Jardim, C; Sitbon, O; Parent, F; Hamid, A; Fadel, E; Dartevelle, P; Simonneau, G; Humbert, M Journal: Thorax Issue: Volume 60:Issue 12(2005) Page Start: 1031 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol. Issue 12 (29th July 2005) Authors: Sitbon, O; McLaughlin, V V; Badesch, D B; Barst, R J; Black, C; Galiè, N; Humbert, M; Rainisio, M; Rubin, L J; Simonneau, G Journal: Thorax Issue: Volume 60:Issue 12(2005) Page Start: 1025 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗